MYRIAD GENETICS INC
MYGN · XNASCIK 899923fmd_0MP6QC3QT4ECMZJ6WDRDNAX0EPManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jul 01, 2008 to Sep 30, 2026, 70 periods
0 filings
From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).
Loading